Genetic Technologies (GTG) Short Interest
Genetic Technologies (ASX:GTG) had 0.00% of shares reported as short positions as of 22 Mar 2021, representing 355,000 shares. Genetic Technologies operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Genetic Technologies
GTG is a global leader in guideline driven genomics based tests in health, wellness and serious disease with its patented geneType polygenic based risk tests and EasyDNA brands. Our portfolio also includes pharmacogenomics, Non-Invasive Prenatal Testi
Short position
Genetic Technologies (ASX:GTG) has 0.00% of its shares on issue reported as short positions as of 22 Mar 2021, or about 355,000 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 1.82% in January 2016. GTG is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4GTG intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss GTG
Start a research thread or post the first pulse update